Skip to content

Study of a Primary Care Hypoglycemia Prevention Program

Pilot Study of a Primary Care Hypoglycemia Prevention Program

Status
Completed
Phases
Unknown
Study type
Interventional
Source
ClinicalTrials.gov
Registry ID
NCT06353217
Enrollment
35
Registered
2024-04-09
Start date
2024-05-22
Completion date
2026-02-01
Last updated
2026-04-09

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Diabetes Mellitus, Hypoglycemia

Brief summary

This is a single site, pre-post pilot study. The objective is to evaluate the acceptability and feasibility of a primary care hypoglycemia prevention program for patients taking hypoglycemia-causing medications. The study will also evaluate relevant process outcomes and clinical outcomes for refining the intervention and planning for a larger efficacy trial.

Interventions

OTHERPatient Group (Hypoglycemia Prevention Program)

The Hypoglycemia Prevention Program: The patient hypoglycemia profile - this is a set of survey questions about hypoglycemia and related aspects of diabetes care. The questions will be administered as an Epic MyChart message sent to the patient in the week prior to the clinic visit, and in the clinic waiting room on a tablet immediately prior to the patient's primary care provider visit.

OTHERPrimary Care Physician Group

The provider hypoglycemia toolkit - this is the report from the patient hypoglycemia profile, which triggers a set of hypoglycemia prevention tools and patient education materials as appropriate. Primary Care Providers will not be exposed to the intervention until all of their patients have completed the Baseline Clinic Visit.

OTHERClinic Staff Group

Clinic staff will provide the tablet to the participant immediately prior to the patient's primary care provider visit.

Sponsors

Johns Hopkins University
Lead SponsorOTHER
National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK)
CollaboratorNIH

Study design

Allocation
NA
Intervention model
SINGLE_GROUP
Primary purpose
PREVENTION
Masking
NONE

Intervention model description

Pre/post pilot study

Eligibility

Sex/Gender
ALL
Age
18 Years to No maximum
Healthy volunteers
No

Inclusion criteria

for patients: * Age 18 years or older * Diabetes mellitus by electronic health record review * Treatment with any of the following medication classes: insulin, sulfonylureas, meglitinides * Community dwelling (not residing in long-term care or a skilled nursing facility) * Receiving primary care from a participating primary care provider at Johns Hopkins Internal Medicine at Green Spring Station * The patient's primary care provider approves their participation

Exclusion criteria

for patients: * Significant cognitive impairment or dementia * Receiving hospice or end of life care * Any other serious illness or condition not compatible with participation as determined by the investigators * Planning to leave area prior to end of study * Investigator discretion

Design outcomes

Primary

MeasureTime frameDescription
Overall acceptability to patientsImmediately after the interventionMean score for overall acceptability on patient intervention evaluation survey (developed for this study, range 1-completely unacceptable, to 5-completely acceptable)
Overall acceptability to primary care providersImmediately after the interventionMean score for overall acceptability on primary care provider intervention evaluation survey (developed for this study, range 1-completely unacceptable, to 5-completely acceptable)
Overall acceptability to clinic staffImmediately after the interventionMean score for overall acceptability on clinic staff intervention evaluation survey (developed for this study, range 1-completely unacceptable, to 5-completely acceptable)

Countries

United States

Contacts

PRINCIPAL_INVESTIGATORScott J Pilla, MD, MHS

Johns Hopkins University

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Apr 10, 2026